Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/NK012> ?p ?o }
Showing triples 1 to 30 of
30
with 100 triples per page.
- NK012 abstract "NK012 is a 'nanodevice' formulation of SN-38 (an irinotecan metabolite). NK012 is an SN-38-releasing polymeric micelle constructed by covalently attaching SN-38 to the block copolymer PEG-PGlu, followed by self-assembly of amphiphilic block copolymers in aqueous media.It has entered phase II clinical trials for triple-negative breast cancer and relapsed small cell lung cancer.".
- NK012 wikiPageID "28278190".
- NK012 wikiPageLength "989".
- NK012 wikiPageOutDegree "11".
- NK012 wikiPageRevisionID "698659478".
- NK012 wikiPageWikiLink Amphiphile.
- NK012 wikiPageWikiLink Category:Experimental_cancer_drugs.
- NK012 wikiPageWikiLink Copolymer.
- NK012 wikiPageWikiLink Irinotecan.
- NK012 wikiPageWikiLink Nanomedicine.
- NK012 wikiPageWikiLink PEG-PGlu.
- NK012 wikiPageWikiLink SN-38.
- NK012 wikiPageWikiLink Small-cell_carcinoma.
- NK012 wikiPageWikiLink Targeted_drug_delivery.
- NK012 wikiPageWikiLink Triple-negative_breast_cancer.
- NK012 wikiPageWikiLinkText "NK012".
- NK012 wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- NK012 wikiPageUsesTemplate Template:Reflist.
- NK012 wikiPageUsesTemplate Template:Update.
- NK012 subject Category:Experimental_cancer_drugs.
- NK012 hypernym A.
- NK012 type Drug.
- NK012 type Drug.
- NK012 comment "NK012 is a 'nanodevice' formulation of SN-38 (an irinotecan metabolite). NK012 is an SN-38-releasing polymeric micelle constructed by covalently attaching SN-38 to the block copolymer PEG-PGlu, followed by self-assembly of amphiphilic block copolymers in aqueous media.It has entered phase II clinical trials for triple-negative breast cancer and relapsed small cell lung cancer.".
- NK012 label "NK012".
- NK012 sameAs Q16944324.
- NK012 sameAs m.0cp19rg.
- NK012 sameAs Q16944324.
- NK012 wasDerivedFrom NK012?oldid=698659478.
- NK012 isPrimaryTopicOf NK012.